Kite Pharma (KITE) Debt to Equity Ratio

Current and historical debt to equity ratio values for Kite Pharma (KITE) over the last 10 years.

Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $10.285B $0.022B
Kite Pharma, Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of cancer immunotherapy products. The Company is developing a pipeline of eACT-based product candidates for the treatment of solid and hematological malignancies. Kite Pharma, Inc. is headquartered in Santa Monica, California.